Corrigendum to “Omalizumab may protect allergic patients against COVID-19: A systematic review” [World Allergy Organ J 16 (2) (2023) 1–19]

• Daniele Giovanni Ghiglioni, MD,
• ET Laura Cozzi, MD,
• Riccardo Castagnoli, MD, PhD,
• Gaia Bruschi, MD,
• Laura Maffeis, MD,
• Paola Giovanna Marchisio, MD,
• GianLuigi Marseglia, MD,
• Amelia Licari, MD, PhD

Affiliations

Daniele Giovanni Ghiglioni, MD

Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, SC Pediatria Pneumoinfettivologia, Milan, Italy; Corresponding author. Via della Commenda 9, 20122, Milano, Italy.

ET Laura Cozzi, MD

University of Milan, Milan, Italy

Riccardo Castagnoli, MD, PhD

Pediatric Clinic, Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy

Gaia Bruschi, MD

University of Milan, Milan, Italy

Laura Maffeis, MD

Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, SC Pediatria Immunoinfettivologia, Milan, Italy

Paola Giovanna Marchisio, MD

Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, SC Pediatria Pneumoinfettivologia, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

GianLuigi Marseglia, MD

Pediatric Clinic, Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy

Amelia Licari, MD, PhD

Pediatric Clinic, Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy